v3.25.0.1
Consolidated Statements of Comprehensive Income - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Statement of Comprehensive Income [Abstract]      
Net earnings $ 4,286 $ 4,873 $ 11,845
Foreign currency translation adjustments, net of tax expense (benefit) of $(39) in 2024, $15 in 2023 and $(10) in 2022 (1,008) 407 (943)
Net investment hedging activities, net of tax expense (benefit) of $133 in 2024, $(109) in 2023 and $152 in 2022 484 (399) 555
Pension and post-employment benefits, net of tax expense (benefit) of $206 in 2024, $(6) in 2023 and $272 in 2022 824 (30) 1,088
Cash flow hedging activities, net of tax expense (benefit) of $16 in 2024, $(19) in 2023 and $5 in 2022 80 (84) 0
Other comprehensive income (loss) 380 (106) 700
Comprehensive income 4,666 4,767 12,545
Comprehensive income attributable to noncontrolling interest 8 10 9
Comprehensive income attributable to AbbVie Inc. $ 4,658 $ 4,757 $ 12,536